Security key
29664W105
- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 28,254,155
- Share change
- -2,556,683
- Total reported value
- $1,253,898,089
- Put/Call ratio
- 188%
- Price per share
- $44.37
- Number of holders
- 151
- Value change
- -$106,658,510
- Number of buys
- 70
- Number of sells
- 69
Report period
Q3 2018
Institutions
151
Top holders
10
ESPR full security history
Newer quarter: Q4 2018
Previous quarter: Q2 2018
Esperion Therapeutics, Inc. SEC filings
Esperion Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29664W105
Recent filing periods:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BB BIOTECH AG |
13F
|
Company |
1.2%
|
3,182,964
|
$124,740,000 | — | 30 Jun 2018 | |
| Meditor Group Ltd |
13F
|
Company |
1%
|
2,629,835
|
$103,063,000 | — | 30 Jun 2018 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.95%
|
2,464,000
|
$96,564,000 | — | 30 Jun 2018 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.95%
|
2,460,157
|
$96,414,000 | — | 30 Jun 2018 | |
| STATE STREET CORP |
13F
|
Company |
0.84%
|
2,173,737
|
$85,191,000 | — | 30 Jun 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.7%
|
1,805,232
|
$70,746,000 | — | 30 Jun 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.6%
|
1,549,222
|
$60,715,000 | — | 30 Jun 2018 | |
| Boxer Capital, LLC |
13F
|
Company |
0.53%
|
1,375,000
|
$53,886,000 | — | 30 Jun 2018 | |
| Aviva Holdings Ltd. |
13F
|
Company |
0.46%
|
1,200,100
|
$47,032,000 | — | 30 Jun 2018 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.42%
|
1,093,596
|
$42,858,000 | — | 30 Jun 2018 | |
| FMR LLC |
13F
|
Company |
0.36%
|
922,979
|
$36,172,000 | — | 30 Jun 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.23%
|
590,104
|
$23,126,000 | — | 30 Jun 2018 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.21%
|
541,012
|
$21,202,000 | — | 30 Jun 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.17%
|
450,158
|
$17,642,000 | — | 30 Jun 2018 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.16%
|
406,361
|
$15,925,000 | — | 30 Jun 2018 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.16%
|
400,813
|
$15,709,000 | — | 30 Jun 2018 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.14%
|
364,100
|
$14,269,000 | — | 30 Jun 2018 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.13%
|
345,671
|
$13,547,000 | — | 30 Jun 2018 | |
| BANK OF NOVA SCOTIA |
13F
|
Company |
0.13%
|
340,000
|
$13,325,000 | — | 30 Jun 2018 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.12%
|
320,815
|
$12,573,000 | — | 30 Jun 2018 | |
| Bellevue Group AG |
13F
|
Company |
0.12%
|
313,520
|
$12,287,000 | — | 30 Jun 2018 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.12%
|
302,903
|
$11,871,000 | — | 30 Jun 2018 | |
| NEXTHERA CAPITAL LP |
13F
|
Company |
0.11%
|
287,300
|
$11,259,000 | — | 30 Jun 2018 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.1%
|
250,000
|
$9,798,000 | — | 30 Jun 2018 | |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT |
13F
|
Company |
0.09%
|
234,715
|
$9,198,000 | — | 30 Jun 2018 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.09%
|
224,071
|
$8,781,000 | — | 30 Jun 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
215,013
|
$8,426,000 | — | 30 Jun 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
214,625
|
$8,411,000 | — | 30 Jun 2018 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
210,468
|
$8,248,000 | — | 30 Jun 2018 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
198,000
|
$7,760,000 | — | 30 Jun 2018 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.07%
|
189,287
|
$7,418,000 | — | 30 Jun 2018 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
169,239
|
$6,632,000 | — | 30 Jun 2018 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.06%
|
151,161
|
$5,924,000 | — | 30 Jun 2018 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
148,704
|
$5,828,000 | — | 30 Jun 2018 | |
| Invesco Ltd. |
13F
|
Company |
0.05%
|
134,821
|
$5,284,000 | — | 30 Jun 2018 | |
| GAM Holding AG |
13F
|
Company |
0.05%
|
133,800
|
$5,244,000 | — | 30 Jun 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
124,308
|
$4,872,000 | — | 30 Jun 2018 | |
| NORGES BANK |
13F
|
Company |
0.05%
|
120,350
|
$4,717,000 | — | 30 Jun 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
111,584
|
$4,373,000 | — | 30 Jun 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
111,389
|
$4,366,000 | — | 30 Jun 2018 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.04%
|
107,350
|
$4,207,000 | — | 30 Jun 2018 | |
| J. Goldman & Co LP |
13F
|
Company |
0.04%
|
92,691
|
$3,633,000 | — | 30 Jun 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
86,817
|
$3,402,000 | — | 30 Jun 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
84,172
|
$3,299,000 | — | 30 Jun 2018 | |
| Spark Investment Management LLC |
13F
|
Company |
0.03%
|
80,600
|
$3,158,000 | — | 30 Jun 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
79,023
|
$3,097,000 | — | 30 Jun 2018 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.03%
|
75,020
|
$2,940,000 | — | 30 Jun 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
68,747
|
$2,694,000 | — | 30 Jun 2018 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.03%
|
67,105
|
$2,630,000 | — | 30 Jun 2018 | |
| Sculptor Capital LP |
13F
|
Company |
0.02%
|
59,700
|
$2,340,000 | — | 30 Jun 2018 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q3 2018
As of 30 Sep 2018,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,254,155 shares.
The largest 10 holders included
BB BIOTECH AG, Meditor Group Ltd, Pentwater Capital Management LP, Partner Fund Management, L.P., BlackRock Inc., STATE STREET CORP, Vanguard Group Inc, BOXER CAPITAL, LLC, Aviva Holdings Ltd., and CREDIT SUISSE AG/.
This page lists
151
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
151
Q3 2018 holders
151
Holder diff
0
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.